Searched for
CURE QUICK PHARMA
Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...- Shiprocket hits IPO runway; Tata ups iPhone anteHappy Tuesday! Shiprocket is all set to start the process for listing in India, sources told ET. This and more in today’s ETtech Morning Di...
- ETMarkets Trade Talk: Boy with broken knee made crores by running after momentum stocks"Out of my total capital of around Rs 15 crore, most of it is held in the form of ETFs. Nifty Auto ETF is now my biggest exposure. Other ET...
- View: Why India must grab a bigger share of the global trade pieTo assess the sustainability of this export boom, and certainly before concluding that this is the dawn of a new regime, a couple of questi...
- Need to create environment for quick scaling up of global COVID vax production: Piyush GoyalHe said India and South Africa along with 57 other WTO (World Trade Organisation) members have co-sponsored a proposal for temporary and li...
- India's healthcare sector is in ICU, time for the FM to write it a big fat chequeAt 4%, India’s total healthcare expenditure as a % of GDP is amongst the lowest globally.
- Aid organisations, varsities team up to ensure access to cheaper vaccinesLast week, at the Global Vaccine Summit hosted by the British government, several countries including India had committed nearly $8 billion...
- Ratan Tata did not buy 50% stake of 17-year-old's start-up, confirms it was minority token investmentTata invested an undisclosed amount in Arjun Deshpande's Generic Aadhaar on Thursday.
- View: Don’t run after this untested hydroxychloroquine ‘cure’The medical community wants a safe and effective remedy of Covid-19, not a trial-and-error scramble. We still don’t know if HCQ fits the bi...
- Not enough ammunition in the market: Sameer NarayanPharma stocks will struggle till earnings improve, says the independent market expert.
- Coronavirus e-misinformation is spreadingThe virus is taking on a life of its own on the internet, putting American social media firms on the defensive
- Set to conquer US, Indian 'Viagras' may give Pfizer a hard timeThe nearing end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.
- Taking public transport to office can work wonders for your heartTrain commuters take an average of 30 per cent more steps per day than people who travel by car.
- How India can double exports and get it up to a trillion dollars in five yearsTo improve, India needs to automate port and customs operations and allow green channel clearances for most consignments.
- Novartis's $475,000 cancer breakthrough heralds new era of curesThe U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...
- India is curing, the world is stumbling, be hot on India: Dipen Sheth, HDFC SecuritiesWe are somewhere close to a sentimental bottom in IT and even more than IT, we are close to now a take off point for pharma and both of the...
- Keen to use India's brain power, says Paul Stoffels, Chief Scientific Officer, Johnson & JohnsonStoffels, who is also worldwide chairman of the US drug major’s pharmaceuticals group, was in India recently to take stock of company’s ope...
- Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug DaclatavirThere might be more companies who might join the patent pool for the drug. Daclatasvir is known to cure multiple genotypes of the Hep C vir...
- Homoeopathy's growth in India is stunning: George VithoulkasCountries such as India, Pakistan and those in South America are lucky that they cannot supply chemical drugs for all their people.
- Withdraw multiple drugs sold under same name: DCGIOn Monday, the Drug Controller General of India asked all state drug regulators to immediately withdraw three separate medicines used as an...
Load More
